Asli Memisoglu

Asli Memisoglu is a seasoned biostatistics professional currently serving as Senior Director of Biostatistics at AbbVie since August 2024. Prior to this role, Asli held a similar position at Cerevel Therapeutics from May 2023 to August 2024 and served as Executive Director of Biostatistics at Seres Therapeutics from April 2021 to May 2023. Asli's extensive experience in the field includes significant positions at Alkermes, Inc., WorldCare Clinical, LLC, Acusphere, Inc., and Abt Associates, as well as a postdoctoral research fellowship at Harvard T.H. Chan School of Public Health. Asli holds a Doctorate and Master's degrees in Epidemiology, Biostatistics, and Molecular Biology from Harvard University, in addition to a Bachelor of Science in Biology from Tufts University.